Interferon-alpha 2b interaction with acenocoumarol

被引：0
|
作者：
Serratrice, J [1 ]
Durand, JM [1 ]
Morange, S [1 ]
机构：
[1] CHU St Marguerite, Dept Internal Med & Toxicol, Marseille, France
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 1998年 / 57卷 / 01期
关键词：
D O I：
10.1002/(SICI)1096-8652(199801)57:1<89::AID-AJH18>3.0.CO;2-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [21] Disclosing the Potential of Fluorinated Ionic Liquids as Interferon-Alpha 2b Delivery Systems
    Ferreira, Margarida L.
    Vieira, Nicole S. M.
    Oliveira, Ana L. S.
    Araujo, Joao M. M.
    Pereiro, Ana B.
    NANOMATERIALS, 2022, 12 (11)
  • [22] Immunochemotherapy with recombinant interferon-alpha 2b plus dacarbazine in the treatment of advanced malignant melanoma
    Strojan, P
    Rudolf, Z
    MELANOMA RESEARCH, 1997, 7 (05) : 420 - 427
  • [23] Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C
    Castellanos Gonzalez, Maria
    Perez Carreras, Mercedes
    Munoz Gomez, Raquel
    Castellano Tortajada, Gregorio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (08): : 584 - 585
  • [24] CONDITIONALLY ACTIVATABLE INTERFERON-ALPHA 2B IMPROVES TOLERABILITY AND EXHIBITS PREFERENTIAL ACTIVITY IN TUMORS
    Berezhnoy, Alexey
    Wang, Hsin
    Lapuyade, Nicole
    Cai, Na
    LePage, Carol
    Winter, Michael
    Krimm, Michael
    Wong, Kenneth
    Ii, Robert Dunn
    McAlister, Sean
    Boustany, Leila
    Paidhungat, Madan
    Belvin, Marcia
    Le Scolan, Erwan
    Daniel, Dylan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1120 - A1120
  • [25] Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C - Reply
    Fabrizi, F
    Martin, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 124 - 124
  • [26] Immunological features of patients with chronic hepatitis C and the effect of interferon-alpha(2b) treatment
    Par, A
    Paal, M
    Gogl, A
    Gervain, J
    Szekeres, J
    Sipos, J
    Bero, T
    Hutter, E
    Mozsik, G
    HEPATOLOGY, 1996, 23 (01) : P210 - P210
  • [27] Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients
    Pol, S
    Thiers, V
    Carnot, F
    Zins, B
    Romeo, R
    Berthelot, P
    Brechot, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 58 - 61
  • [28] Effect of interferon-alpha(2b) administration on rat liver regeneration after partial hepatectomy
    Theocharis, SE
    Margeli, AP
    Skaltsas, SD
    Skopelitou, AS
    Mykoniatis, MG
    Kittas, CN
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (09) : 1981 - 1986
  • [29] Inhibition of choroidal melanoma by interferon alpha 2b (IFNα2b)
    Neale, M
    Myatt, N
    Hungerford, JL
    Plowman, PN
    Cree, IA
    ANNALS OF ONCOLOGY, 1998, 9 : 88 - 88
  • [30] Interferon-alpha 2b and ribavirin for recurrent hepatitis C in liver transplantation - A single center experience
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    Zetterman, RK
    Sorrell, MF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S94 - S95
12345